Search for publications in the Transfection Database with Polyplus transfection reagents or for transfection conditions.

Over 6000 publications, 1000 cell lines and primary cells available.

Order by :  
Found 5890 results :
Cell Linein vitro
in vivo		Delivered MoleculeReagentResults & Citations
Expi293Fin vitroDNAFectoPRO
Broketa, M.. et al. (2023)

JCI Insight . 8, e166602
Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics
More details
HEK-293in vitroDNAFectoPRO
Aira, C.. et al. (2023)

Pathogens. 12, 811
Improving African Swine Fever Surveillance Using Fluorescent Rapid Tests
More details
HEK-293Fin vitroDNAFectoPRO
Hasan, S. et al. (2023)

Nat Commun. 14, 3460
Atomic model for core modifying region of human fatty acid synthase in complex with Denifanstat
More details
C2C12in vitromRNAjetMESSENGER
Pontes AP. et al. (2024)

Biomater Adv 156, 213713
A poly(amidoamine)-based polymeric nanoparticle platform for efficient in vivo delivery of mRNA
More details
HEK-293Fin vitroDNAFectoPRO
Lenza, M. P.. et al. (2023)

Nat Commun. 14, 3496
Structural insights into Siglec-15 reveal glycosylation dependency for its interaction with T cells through integrin CD11b
More details
Expi293Fin vitroDNAFectoPRO
Nagira, Y.. et al. (2023)

Mol Cancer Ther . 14, 1063-1072
S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells
More details
Expi293Fin vitroDNAFectoPRO
Guo, S.. et al. (2023)

Cell Discov 9, 79
Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine
More details
Expi293Fin vitroDNAFectoPRO
Mandal K. et al. (2023)

Nat Cancer. 4, 1592-1609
Structural surfaceomics reveals an AML-specific conformation of Integrin-β2 as a CAR-T therapy target
More details
HEK-293-Fin vitroDNAFectoPRO
Burn Aschner, C.. et al. (2023)

Sci Transl Med . 15, eadf4549
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo
More details
Expi293Fin vitroDNAFectoPRO
Welch, S. R.. et al. (2023)

Sci Adv . 9, eadh4057
Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination
More details
« Previous Results
Next Results »